Literature DB >> 31002306

Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates.

Kenichi Lee1, Shu-Ichi Nakayama1, Kayo Osawa2, Hiroyuki Yoshida2, Soichi Arakawa3, Kei-Ichi Furubayashi4, Hiroshi Kameoka5, Ken Shimuta1, Takuya Kawahata6, Magnus Unemo7, Makoto Ohnishi1.   

Abstract

OBJECTIVES: Ceftriaxone resistance in Neisseria gonorrhoeae is a major public health concern globally because a high-dose (1 g) injection of ceftriaxone is the only remaining option for empirical monotherapy of gonorrhoea. The ceftriaxone-resistant gonococcal strain FC428, cultured in Osaka in 2015, is suspected to have spread nationally and internationally. We describe the complete finished genomes of FC428 and two closely related isolates from Osaka in 2015, and examine the genomic epidemiology of these isolates plus three ceftriaxone-resistant gonococcal isolates from Osaka and Hyogo in 2016-17 and four ceftriaxone-resistant gonococcal isolates cultured in 2017 in Australia, Canada and Denmark.
METHODS: During 2015-17, we identified six ceftriaxone-resistant gonococcal isolates through our surveillance systems in Kyoto, Osaka and Hyogo. Antimicrobial susceptibility testing (six antimicrobials) was performed using Etest. Complete whole-genome sequences of the first three isolates (FC428, FC460 and FC498) from 2015 were obtained using PacBio RS II and Illumina MiSeq sequencing. The three complete genome sequences and draft genome sequences of the three additional Japanese (sequenced with Illumina MiSeq) and four international ceftriaxone-resistant isolates were compared.
RESULTS: Detailed genomic analysis suggested that the Japanese isolates (FC428, FC460, FC498, KU16054, KM383 and KU17039) and the four international MLST ST1903 isolates from Australia, Canada and Denmark formed four linked subclades.
CONCLUSIONS: Using detailed genomic analysis, we describe the clonal expansion of the ceftriaxone-resistant N. gonorrhoeae strain FC428, initially identified in 2015 in Japan, and closely related isolates. FC428 and its close relatives show some genomic diversity, suggesting multiple genetic subclades are already spreading internationally.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID: 31002306     DOI: 10.1093/jac/dkz129

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Bypassing Phase Variation of Lipooligosaccharide (LOS): Using Heptose 1 Glycan Mutants To Establish Widespread Efficacy of Gonococcal Anti-LOS Monoclonal Antibody 2C7.

Authors:  Srinjoy Chakraborti; Sunita Gulati; Bo Zheng; Frank J Beurskens; Janine Schuurman; Peter A Rice; Sanjay Ram
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

2.  A Loop-Mediated Isothermal Amplification Assay Targeting Neisseria gonorrhoeae penA-60.001.

Authors:  Ken Shimuta; Shu-Ichi Nakayama; Hideyuki Takahashi; Makoto Ohnishi
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

3.  Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928-2013): antimicrobial use/misuse selects for resistance and drives evolution.

Authors:  Daniel Golparian; Simon R Harris; Leonor Sánchez-Busó; Steen Hoffmann; William M Shafer; Stephen D Bentley; Jörgen S Jensen; Magnus Unemo
Journal:  BMC Genomics       Date:  2020-02-03       Impact factor: 3.969

4.  Impact of the gonococcal FC428 penA allele 60.001 on ceftriaxone resistance and biological fitness.

Authors:  Ke Zhou; Shao-Chun Chen; Fan Yang; Stijn van der Veen; Yue-Ping Yin
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

5.  First National Genomic Epidemiological Study of Neisseria gonorrhoeae Strains Spreading Across Sweden in 2016.

Authors:  Ronza Hadad; Daniel Golparian; Inga Velicko; Anna-Karin Ohlsson; Ylva Lindroth; Eva-Lena Ericson; Hans Fredlund; Lars Engstrand; Magnus Unemo
Journal:  Front Microbiol       Date:  2022-01-13       Impact factor: 5.640

6.  Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022.

Authors:  Sonja Pleininger; Alexander Indra; Daniel Golparian; Florian Heger; Stefanie Schindler; Susanne Jacobsson; Stefan Heidler; Magnus Unemo
Journal:  Euro Surveill       Date:  2022-06

Review 7.  Sexually transmitted infections and female reproductive health.

Authors:  Olivia T Van Gerwen; Christina A Muzny; Jeanne M Marrazzo
Journal:  Nat Microbiol       Date:  2022-08-02       Impact factor: 30.964

Review 8.  Bioinformatics tools used for whole-genome sequencing analysis of Neisseria gonorrhoeae: a literature review.

Authors:  Reema Singh; Anthony Kusalik; Jo-Anne R Dillon
Journal:  Brief Funct Genomics       Date:  2022-04-11       Impact factor: 4.840

9.  Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015-16.

Authors:  Pham Thi Lan; Daniel Golparian; Johan Ringlander; Le Van Hung; Nguyen Van Thuong; Magnus Unemo
Journal:  J Antimicrob Chemother       Date:  2020-06-01       Impact factor: 5.790

10.  Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017-2018.

Authors:  Qianqin Yuan; Yamei Li; Leshan Xiu; Chi Zhang; Yaoyang Fu; Chuanhao Jiang; Lingli Tang; Junping Peng
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.